Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

APGN Apexign Inc

0.00 (0.00%)
Jun 13 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 0.36
Ask Price 0.418
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Apexign Inc APGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.3851 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.3851 0.3851
Trades Volume Avg Volume 52 Week Range
0 0 - 0.3542 - 0.5415
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.3851 USD

Apexign Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 9.57M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Apexign News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No APGN Message Board. Create One! See More Posts on APGN Message Board See More Message Board Posts

Historical APGN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.51160.54150.35420.446972447,749-0.1265-24.73%
3 Years15.0031.350.33052.06632,807-14.61-97.43%
5 Years15.0031.350.33052.06632,807-14.61-97.43%

Apexign Description

Apexigen Inc is a clinical-stage biopharmaceutical company focusing on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. The company's pipeline of immuno-oncology therapeutic candidates is led by sotigalimab, which is in clinical development, and also includes several preclinical stage immune-oncology programs.

Your Recent History

Delayed Upgrade Clock